• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利艾滋病患者中艾滋病发病率下降,艾滋病患者报告人数增加。

Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

作者信息

Castelnuovo B, Chiesa E, Rusconi S, Adorni F, Bongiovanni M, Melzi S, Cicconi P, Tordato F, Meroni L, Bini T, d'Arminio Monforte A

机构信息

Institute of Infectious Diseases and Tropical Medicine, University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy.

出版信息

Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):663-9. doi: 10.1007/s10096-003-1038-8. Epub 2003 Oct 21.

DOI:10.1007/s10096-003-1038-8
PMID:14569430
Abstract

Presented here are the results of a cohort study conducted on 3,483 consecutive HIV/AIDS patients between January 1993 and December 2000 to determine trends in AIDS incidence and presentation. The incidence of AIDS was calculated in the general population and examined further according to gender, age (< or = or >49 years), and heterosexual behaviour as a risk factor for HIV. Multivariate analysis was used to identify variables associated with AIDS presenters (defined as patients diagnosed with AIDS within 1 month of the first HIV-positive test). The numbers of patients with AIDS classified as (i) AIDS presenters, (ii) known HIV-positive patients on antiretroviral treatment, and (iii) known HIV-positive patients not receiving antiretroviral treatment were calculated. The overall incidence of AIDS decreased over time, mainly due to the lower number of patients on antiretroviral treatment developing AIDS. Factors associated with a higher risk of being an AIDS presenter were male gender and year of HIV diagnosis. Among patients with AIDS, the proportion of AIDS presenters increased from 13.8% prior to 1997 (when protease inhibitors were introduced in Italy) to 32.5% after 1997. Variables predictive of being an AIDS presenter were male gender, age at diagnosis, and AIDS diagnosis in the years 1997-2000. Heterosexuals had a higher risk of being AIDS presenters and a lower risk of being HIV-positive and not receiving antiretroviral treatment than intravenous drug users. In Italy, AIDS occurs mainly in subjects unaware of their HIV status (especially males, the elderly, and those infected heterosexually) or in patients refusing antiretroviral therapy (mainly intravenous drug users who do not refer to specialised centres).

摘要

本文呈现了一项队列研究的结果,该研究针对1993年1月至2000年12月期间连续收治的3483例艾滋病毒/艾滋病患者展开,旨在确定艾滋病的发病率及临床表现趋势。在普通人群中计算艾滋病发病率,并根据性别、年龄(≤49岁或>49岁)以及作为艾滋病毒危险因素的异性性行为作进一步分析。采用多变量分析来确定与艾滋病确诊者(定义为在首次艾滋病毒检测呈阳性后1个月内被诊断为艾滋病的患者)相关的变量。计算了被分类为(i)艾滋病确诊者、(ii)接受抗逆转录病毒治疗的已知艾滋病毒阳性患者、(iii)未接受抗逆转录病毒治疗的已知艾滋病毒阳性患者的人数。随着时间推移,艾滋病的总体发病率有所下降,这主要归因于接受抗逆转录病毒治疗的患者中患艾滋病的人数减少。与成为艾滋病确诊者风险较高相关的因素为男性性别及艾滋病毒诊断年份。在艾滋病患者中,艾滋病确诊者的比例从1997年之前(意大利引入蛋白酶抑制剂时)的13.8%增至1997年之后的32.5%。预测成为艾滋病确诊者的变量为男性性别、诊断时的年龄以及1997 - 2000年期间的艾滋病诊断情况。与静脉吸毒者相比,异性恋者成为艾滋病确诊者的风险较高,而成为艾滋病毒阳性且未接受抗逆转录病毒治疗者的风险较低。在意大利,艾滋病主要发生在未意识到自身艾滋病毒感染状况的人群(尤其是男性、老年人以及异性感染人群)或拒绝接受抗逆转录病毒治疗的患者(主要是未前往专科中心就诊的静脉吸毒者)中。

相似文献

1
Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.意大利艾滋病患者中艾滋病发病率下降,艾滋病患者报告人数增加。
Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):663-9. doi: 10.1007/s10096-003-1038-8. Epub 2003 Oct 21.
2
Clinical features of HIV/AIDS and various opportunistic infections in relation to antiretroviral status among HIV seropositive individuals from Central Nepal.尼泊尔中部HIV血清阳性个体中,HIV/AIDS的临床特征及与抗逆转录病毒治疗状态相关的各种机会性感染
Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):355-9. doi: 10.3126/kumj.v7i4.2754.
3
Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.HIV-1感染女性临床艾滋病表现及生存情况的变化趋势
J Womens Health (Larchmt). 2004 Jul-Aug;13(6):719-30. doi: 10.1089/jwh.2004.13.719.
4
Update on HIV/AIDS in Thailand.泰国艾滋病病毒/艾滋病最新情况
J Med Assoc Thai. 2001 Jun;84 Suppl 1:S1-17.
5
[AIDS and HIV infections in Poland in 2001].2001年波兰的艾滋病与艾滋病毒感染情况
Przegl Epidemiol. 2003;57(1):165-77.
6
Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy.在意大利,随着联合抗逆转录病毒疗法的引入,艾滋病患者中艾滋病毒感染晚期诊断的比例不断增加。
J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):71-6. doi: 10.1097/00042560-200009010-00010.
7
Epidemiological changes in AIDS and HIV infection in Italy.意大利艾滋病及艾滋病毒感染的流行病学变化
Scand J Infect Dis Suppl. 2003;106:12-6. doi: 10.1080/03008870310009588.
8
Increasing proportion of late testers among AIDS cases in Italy, 1996-2002.1996 - 2002年意大利艾滋病病例中晚期检测者比例上升。
AIDS Care. 2005 Oct;17(7):834-41. doi: 10.1080/09540120500038397.
9
Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre.比利时单中心人类免疫缺陷病毒(HIV)诊断延迟呈现的结果
Acta Clin Belg. 2014 Jan-Feb;69(1):33-9. doi: 10.1179/0001551213Z.00000000014.
10
Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.HIV 感染的晚期表现:西西里东部延迟诊断和生存的预测因素。
Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2218-24.

引用本文的文献

1
Socio-demographic and clinical determinants of late presentation among patients newly diagnosed with HIV in the Eastern Cape, South Africa.南非东开普省新诊断艾滋病毒患者延迟就诊的社会人口学和临床决定因素。
Medicine (Baltimore). 2019 Feb;98(8):e14664. doi: 10.1097/MD.0000000000014664.
2
Sociodemographic and Health Profile of Heterosexual Men Living With HIV in Ontario, Canada.加拿大安大略省感染艾滋病毒的异性恋男性的社会人口统计学和健康概况。
Am J Mens Health. 2017 Jul;11(4):855-862. doi: 10.1177/1557988317696639. Epub 2017 Mar 1.
3
Late Presentation of HIV Infection: Prevalence, Trends, and the Role of HIV Testing Strategies in Guangzhou, China, 2008-2013.

本文引用的文献

1
2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.2001年美国公共卫生署/美国感染病学会关于预防感染人类免疫缺陷病毒者机会性感染的指南。
HIV Clin Trials. 2001 Nov-Dec;2(6):493-554. doi: 10.1310/AQML-UABK-5LLB-E615.
2
Understanding delay to medical care for HIV infection: the long-term non-presenter.了解艾滋病毒感染的医疗延误情况:长期未就诊者。
AIDS. 2001 Jan 5;15(1):77-85. doi: 10.1097/00002030-200101050-00012.
3
Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy.
中国广州2008 - 2013年HIV感染的晚期诊断:患病率、趋势及HIV检测策略的作用
Biomed Res Int. 2016;2016:1631878. doi: 10.1155/2016/1631878. Epub 2016 Sep 27.
4
Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease.在 HIV-1 诊断时已处于晚期疾病的患者中,不同抗逆转录病毒联合治疗策略的治疗反应率及其决定因素。
BMC Infect Dis. 2011 Dec 14;11:341. doi: 10.1186/1471-2334-11-341.
5
Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009.巴塞罗那(西班牙)2001-2009 年期间 HIV 感染晚发现的流行病学特征和预测因素。
AIDS Res Ther. 2011 Jul 6;8(1):22. doi: 10.1186/1742-6405-8-22.
在意大利,随着联合抗逆转录病毒疗法的引入,艾滋病患者中艾滋病毒感染晚期诊断的比例不断增加。
J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):71-6. doi: 10.1097/00042560-200009010-00010.
4
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.依非韦伦加齐多夫定和拉米夫定、依非韦伦加茚地那韦以及茚地那韦加齐多夫定和拉米夫定用于治疗成人HIV-1感染。006研究团队。
N Engl J Med. 1999 Dec 16;341(25):1865-73. doi: 10.1056/NEJM199912163412501.
5
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.欧洲HIV-1感染患者死亡率模式的变化。欧洲SIDA研究小组。
Lancet. 1998 Nov 28;352(9142):1725-30. doi: 10.1016/s0140-6736(98)03201-2.
6
Determinants of delayed diagnosis of HIV infection in France, 1993-1995.1993 - 1995年法国HIV感染延迟诊断的决定因素
AIDS. 1998 May 7;12(7):795-800. doi: 10.1097/00002030-199807000-00016.
7
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.晚期人类免疫缺陷病毒感染患者的发病率和死亡率下降。HIV门诊研究调查人员。
N Engl J Med. 1998 Mar 26;338(13):853-60. doi: 10.1056/NEJM199803263381301.
8
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.新型抗逆转录病毒联合疗法对瑞士HIV感染患者的影响:前瞻性多中心研究。瑞士HIV队列研究。
BMJ. 1997 Nov 8;315(7117):1194-9. doi: 10.1136/bmj.315.7117.1194.
9
Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA.蛋白酶抑制剂对法国10个艾滋病参考中心艾滋病界定事件及住院情况的影响。法国国家艾滋病防治中心联盟
AIDS. 1997 Oct;11(12):F101-5. doi: 10.1097/00002030-199712000-00003.
10
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.一项针对人类免疫缺陷病毒感染且每立方毫米CD4细胞计数为200或更低的患者,使用两种核苷类似物加茚地那韦的对照试验。艾滋病临床试验组320研究团队。
N Engl J Med. 1997 Sep 11;337(11):725-33. doi: 10.1056/NEJM199709113371101.